ASRIX | BKRDX | ASRIX / BKRDX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 9 years | - |
Gain YTD | 6.779 | 11.610 | 58% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000000 | 20% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 614M | 3.07B | 20% |
Annual Yield % from dividends | 3.61 | 3.10 | 116% |
Returns for 1 year | 16.71 | 23.20 | 72% |
Returns for 3 years | -0.43 | -0.97 | 45% |
Returns for 5 years | 7.77 | 10.34 | 75% |
Returns for 10 years | 36.99 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FRBRX | 159.78 | 1.35 | +0.85% |
Franklin Biotechnology Discovery R6 | |||
SEKIX | 18.38 | -0.01 | -0.05% |
DWS Emerging Markets Equity Inst | |||
IPFPX | 53.48 | -0.11 | -0.21% |
Poplar Forest Partners Institutional | |||
FFGGX | 39.35 | -0.10 | -0.25% |
American Funds Global Balanced 529-F-2 | |||
GEMSX | 21.00 | -0.06 | -0.28% |
Goldman Sachs Emerging Markets Eq Svc |